Investors

Egetis is an innovative, unique, and integrated pharmaceutical drug development company, focusing on projects in late-stage development for treatment of serious rare/niche diseases with significant unmet medical needs in the orphan drug segment

IR-contact

 

Nicklas Westerholm, CEO
nicklas.westerholm@egetis.com

Marie-Louise Alamaa, CFO
marie-louise.alamaa@egetis.com

Calendar and upcoming reports

August 19, 2021
Interim report April-June

September 1-2, 2021
Pareto healthcare conference

Show more events

Share

Twitter
LinkedIn

Contact us

Address: Klara Norra Kyrkogata 26, SE 111 22 Stockholm, Sweden

Phone: +46 8 679 72 10

E-mail: info@egetis.com